Related Experiment Video
Updated: Aug 29, 2025

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
An attention mechanism-based LSTM network for cancer kinase activity prediction
Danishuddin1,2, V Kumar1, G Lee3
1Department of Bio & Medical Big Data (BK21 Four Program), Division of Life Sciences, Research Institute of Life Sciences, Gyeongsang National University, Jinju, Korea.
Abstract:
Despite the endeavours and achievements made in treating cancers during the past decades, resistance to available kinase drugs continues to be a major problem in cancer therapies. Thus, it is highly desirable to develop computational models that can predict the bioactivity of a compound against cancer kinases. Here, we present a Long Short-Term Memory (LSTM) framework for predicting the activities of lead molecules against seven different kinases. A total of 14,907 compounds from the ChEMBL database were selected for model building. Two different molecular representations, namely, 2D descriptors and MACCS fingerprints were subjected to the LSTM method for the training process. We also successfully integrated an attention mechanism into our model, which helped us to interpret the contribution of chemical features on kinase activity. The attention mechanism extracted the significant chemical moieties more effectively by taking them into consideration during the activity prediction. The recorded accuracies in the test sets for both 2D descriptors and MACCS fingerprints-based models were 0.81 and 0.78, respectively. The receiver operating characteristic curve (ROC)-area under the curve (AUC) score for both models was in the range of 0.8-0.99. The proposed framework can be a good starting point for the development of new cancer kinase drugs.
Insights
This study introduces a Long Short-Term Memory (LSTM) framework to predict cancer kinase drug activity. The model accurately identifies potential drug candidates, aiding in the development of new cancer therapies.
Area of Science:
- Computational chemistry
- Drug discovery
- Bioinformatics
Background:
- Kinase drug resistance remains a significant challenge in cancer therapy.
- Predictive models for compound bioactivity against cancer kinases are highly desirable.
Purpose of the Study:
- To develop a Long Short-Term Memory (LSTM) framework for predicting lead molecule activities against seven cancer kinases.
- To integrate an attention mechanism for interpreting chemical feature contributions to kinase activity.
Main Methods:
- Utilized 14,907 compounds from the ChEMBL database for model training.
- Employed two molecular representations: 2D descriptors and MACCS fingerprints with the LSTM method.
- Integrated an attention mechanism to identify significant chemical moieties influencing kinase activity.
Main Results:
- Achieved test set accuracies of 0.81 for 2D descriptors and 0.78 for MACCS fingerprints.
- Reported Receiver Operating Characteristic (ROC)-Area Under the Curve (AUC) scores ranging from 0.8 to 0.99 for both models.
- Demonstrated effective extraction of significant chemical moieties by the attention mechanism.
Conclusions:
- The proposed LSTM framework shows promise for predicting cancer kinase activities.
- This computational approach can serve as a foundation for developing novel anti-cancer kinase drugs.
- The integrated attention mechanism enhances the interpretability of the predictive model.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Amplifying Signals via Enzymatic Cascade

